Compare ASH & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASH | HTGC |
|---|---|---|
| Founded | 1924 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2016 | 2004 |
| Metric | ASH | HTGC |
|---|---|---|
| Price | $73.33 | $17.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $65.57 | $18.86 |
| AVG Volume (30 Days) | 597.1K | ★ 1.8M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | 3.38% | ★ 12.13% |
| EPS Growth | N/A | ★ 14.91 |
| EPS | 0.43 | ★ 0.90 |
| Revenue | ★ $1,824,000,000.00 | N/A |
| Revenue This Year | $2.58 | $11.18 |
| Revenue Next Year | $4.28 | $5.24 |
| P/E Ratio | $171.95 | ★ $19.47 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $46.30 | $13.70 |
| 52 Week High | $78.25 | $19.62 |
| Indicator | ASH | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 65.28 |
| Support Level | $71.58 | $16.97 |
| Resistance Level | $74.99 | $19.05 |
| Average True Range (ATR) | 1.48 | 0.23 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 59.76 | 85.37 |
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.